1-12 of 12
Wei Zou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5176: Tumor dynamic model-based decision support for phase Ib immunotherapy combination studies

René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Y. Jin
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5176.
DOI: https://doi.org/10.1158/1538-7445.AM2022-5176
Published: 15 June 2022
View article
Journal Articles

Abstract CT076: IMpower150: Efficacy of atezolizumab (atezo) plus bevacizumab (bev) and chemotherapy (chemo) in 1L metastatic nonsquamous NSCLC (mNSCLC) across key subgroups

Marcin Kowanetz, Mark A. Socinski, Wei Zou, Mark McCleland, Nancy Yang, Ariel Lopez Chavez, Alexander Spira, Julien Mazières, Fadi Braiteh, David Shames, Alan Sandler, Martin Reck
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT076.
DOI: https://doi.org/10.1158/1538-7445.AM2018-CT076
Published: 01 July 2018
View article
Journal Articles

Abstract 5707: On-treatment changes in CRP as a surrogate for overall survival for atezolizumab benefit in 2nd line NSCLC

Namrata Patil, Wei Zou, Simonetta Mocci, Vinita Gupta, Luciana Molinero, Alan Sandler, Marcus Ballinger, Susan Flynn, Marcin Kowanetz, Priti Hegde
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5707.
DOI: https://doi.org/10.1158/1538-7445.AM2018-5707
Published: 01 July 2018
View article
Journal Articles

Antagonizing Integrin β3 Increases Immunosuppression in Cancer

Xinming Su, Alison K. Esser, Sarah R. Amend, Jingyu Xiang, Yalin Xu, Michael H. Ross, Gregory C. Fox, Takayuki Kobayashi, Veronica Steri, Kirsten Roomp, Francesca Fontana, Michelle A. Hurchla, Brett L. Knolhoff, Melissa A. Meyer, Elizabeth A. Morgan, Julia C. Tomasson, Joshua S. Novack, Wei Zou, Roberta Faccio, Deborah V. Novack, Stephen D. Robinson, Steven L. Teitelbaum, David G. DeNardo, Jochen G. Schneider, Katherine N. Weilbaecher
Journal: Cancer Research
Cancer Res (2016) 76 (12): 3484–3495.
DOI: https://doi.org/10.1158/0008-5472.CAN-15-2663
Published: 14 June 2016
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 1768: Comprehensive mass spectrometry based metabolomic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer

Shiro Urayama, Wei Zou, Vladimir Tolstikov
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1768.
DOI: https://doi.org/10.1158/1538-7445.AM10-1768
Published: 15 April 2010
View article
Journal Articles

CD47 Regulates Bone Mass and Tumor Metastasis to Bone

Özge Uluçkan, Stephanie N. Becker, Hongju Deng, Wei Zou, Julie L. Prior, David Piwnica-Worms, William A. Frazier, Katherine N. Weilbaecher
Journal: Cancer Research
Cancer Res (2009) 69 (7): 3196–3204.
DOI: https://doi.org/10.1158/0008-5472.CAN-08-3358
Published: 01 April 2009
View article
PDF
Includes: Supplementary data
Journal Articles

Coupling of Endoplasmic Reticulum Stress to CDDO-Me–Induced Up-regulation of Death Receptor 5 via a CHOP–Dependent Mechanism Involving JNK Activation

Wei Zou, Ping Yue, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2008) 68 (18): 7484–7492.
DOI: https://doi.org/10.1158/0008-5472.CAN-08-1318
Published: 14 September 2008
View article
PDF
Journal Articles

CAAT/Enhancer Binding Protein Homologous Protein–Dependent Death Receptor 5 Induction Is a Major Component of SHetA2-Induced Apoptosis in Lung Cancer Cells

Yi-Dan Lin, Shuzhen Chen, Ping Yue, Wei Zou, Doris M. Benbrook, Shengquan Liu, Thanh C. Le, K. Darrell Berlin, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2008) 68 (13): 5335–5344.
DOI: https://doi.org/10.1158/0008-5472.CAN-07-6209
Published: 01 July 2008
View article
PDF
Includes: Supplementary data
Journal Articles

The Farnesyltransferase Inhibitor R115777 Up-regulates the Expression of Death Receptor 5 and Enhances TRAIL-Induced Apoptosis in Human Lung Cancer Cells

Yuanzheng Qiu, Xiangguo Liu, Wei Zou, Ping Yue, Sagar Lonial, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2007) 67 (10): 4973–4980.
DOI: https://doi.org/10.1158/0008-5472.CAN-06-4044
Published: 17 May 2007
View article
PDF
Journal Articles

c-Jun N-terminal kinase (JNK)-independent c-FLIP downregulation contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate     (CDDO-Me) in human lung cancer cells.

Wei Zou, Shuzhen Chen, Xiangguo Liu, Ping Yue, Michael B. Sporn, Fadlo R. Khur, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5139.
Published: 01 May 2007
View article
Journal Articles

PPARγ ligands induce death receptor 5 (DR5) expression and redistribution in lipid rafts and enhance TRAIL-induced apoptosis in human lung cancer cells

Wei Zou, Xiangguo Liu, Ping Yue, Fadlo R Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 180.
Published: 15 April 2006
View article
Journal Articles

c-Jun NH2-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer Cells

Wei Zou, Xiangguo Liu, Ping Yue, Zhongmei Zhou, Michael B. Sporn, Reuben Lotan, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2004) 64 (20): 7570–7578.
DOI: https://doi.org/10.1158/0008-5472.CAN-04-1238
Published: 15 October 2004
View article
PDF